Literature DB >> 10363863

Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment.

S P Marso1, G Steg, T Plokker, D Holmes, S J Park, K Kosuga, H Tamai, C Macaya, J Moses, H White, S F Verstraete, S G Ellis.   

Abstract

The ULTIMA registry was a prospective, multicenter, international registry of 277 patients who underwent percutaneous coronary interventions of unprotected left main trunk stenosis. The 40 patients who underwent an emergency percutaneous left main intervention for acute myocardial infarction are the focus of this study. We compared the results of primary angioplasty with primary stenting, characterizing both the short-term (in-hospital) and long-term (12-month) outcomes. Of the 40 patients, 23 underwent primary angioplasty, whereas 17 underwent primary stenting. The angiographic success rate was an 88% for the cohort. The in-hospital death or coronary artery bypass grafting rate was 65% for the entire group, 74% for the percutaneous transluminal coronary angioplasty group (PTCA), and 53% for the stent group (p = 0.2). The in-hospital death rate was 55% for the entire cohort, 70% for the PTCA group, and 35% for the stent group (p = 0.1). The 12-month rate of death or bypass surgery was 83% and 58% for the PTCA and stent groups, respectively (p = 0.047). The 12-month survival rate was 35% and 53% for the PTCA and stent groups, respectively (p = 0.18). Bypass surgery was required in 6 patients in the PTCA group and 2 patients in the stent group (p = 0.07). Patients undergoing percutaneous interventions for unprotected left main myocardial stenosis during an acute myocardial infarction are critically ill; an initial percutaneous revascularization approach appears feasible and may be the preferred revascularization strategy. Primary stenting was associated with improved clinical outcomes.

Entities:  

Mesh:

Year:  1999        PMID: 10363863     DOI: 10.1016/s0002-9149(99)00139-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents.

Authors:  Martino Pepe; Massimo Napodano; Giuseppe Tarantini; Chiara Fraccaro; Ada Cutolo; Diletta Peluso; Giambattista Isabella; Angelo Ramondo; Sabino Iliceto
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

2.  Long-term prognosis of patients with acute myocardial infarction due to unprotected left main coronary artery disease: a single-centre experience over 14 years.

Authors:  Li Xu; Hao Sun; Le-Feng Wang; Xin-Chun Yang; Kui-Bao Li; Da-Peng Zhang; Hong-Shi Wang; Wei-Ming Li
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

3.  Left main stem coronary disease: the case for percutaneous coronary intervention in a high risk patient with complex disease.

Authors:  K Kosuga; H Tamai
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

4.  Left main coronary artery thrombus: a case series with different outcomes.

Authors:  Rajiv Gupta; Mohammed A Rahman; Barry F Uretsky; Ernst R Schwarz
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

5.  Endovascular repair of symptomatic abdominal aortic aneurysm complicated by postoperative acute myocardial infarction with cardiogenic shock.

Authors:  Stefan Brunner; Reinhard Kopp; Wolfgang-Michael Franz
Journal:  Clin Res Cardiol       Date:  2007-02-26       Impact factor: 5.460

6.  Revascularisation of the unprotected left main: surgery or angioplasty?

Authors:  G A J Jessurun; R W M Hautvast; R A Tio
Journal:  Neth Heart J       Date:  2001-12       Impact factor: 2.380

7.  Survival of acute ST-elevation myocardial infarction with total occlusion of the left main coronary artery.

Authors:  Josef Friedenberger; Holger Thiele
Journal:  BMJ Case Rep       Date:  2010-10-28

8.  Use of bio-mimetic three-dimensional technology in therapeutics for heart disease.

Authors:  Vahid Serpooshan; Mingming Zhao; Scott A Metzler; Ke Wei; Parisha B Shah; Andrew Wang; Morteza Mahmoudi; Andrey V Malkovskiy; Jayakumar Rajadas; Manish J Butte; Daniel Bernstein; Pilar Ruiz-Lozano
Journal:  Bioengineered       Date:  2014-01-14       Impact factor: 3.269

Review 9.  Treatment of unprotected left main coronary artery stenosis with a drug eluting stent in a heart transplant patient with allograft vasculopathy.

Authors:  G Matos; L Steen; F Leya
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

10.  Percutaneous Coronary Intervention for Left Main Coronary Artery Disease - A Single Hospital Experience without On-Site Cardiac Surgery.

Authors:  Hsiao-Yang Cheng; Kuang-Te Wang; Wen-Hsiung Lin; Jui-Peng Tsai; Yung-Tzi Chen
Journal:  Acta Cardiol Sin       Date:  2015-07       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.